Article
Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions.
Human vaccines & immunotherapeutics - 30 Nov 2022
Dhawan Manish, Sharma Abhilasha, Priyanka, Thakur Nanamika, Rajkhowa Tridib Kumar, Choudhary Om Prakash
Abstract excerpt
Since commencement of COVID-19 pandemic, several SARS-CoV-2 variants have emerged amid containment efforts via vaccination. The Delta variant (B.1.617.2), discovered in October 2020, was designated as a VOC by the WHO on May 11, 2021. The enhanced transmissibility of Delta variant has been associated with critical mutations such as D614G, L452R, P681R, and T478K in the S-protein. The increased affinity of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
